SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-23-000075
Filing Date
2023-03-23
Accepted
2023-03-23 17:25:59
Documents
19
Period of Report
2023-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20230323.htm   iXBRL 8-K 45683
2 EX-10 exc_compmins2-9x23v1x202.htm EX-10 17977
6 exc_compmins2-9x23v1x202001.jpg GRAPHIC 250792
7 exc_compmins2-9x23v1x202002.jpg GRAPHIC 252171
8 exc_compmins2-9x23v1x202003.jpg GRAPHIC 170809
9 exc_compmins2-9x23v1x202004.jpg GRAPHIC 186041
10 exc_compmins2-9x23v1x202005.jpg GRAPHIC 248251
11 exc_compmins2-9x23v1x202006.jpg GRAPHIC 149631
  Complete submission text file 0001367644-23-000075.txt   1938987

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20230323.xsd EX-101.SCH 1965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20230323_lab.xml EX-101.LAB 25154
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20230323_pre.xml EX-101.PRE 13100
13 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20230323_htm.xml XML 4436
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23757165
SIC: 2834 Pharmaceutical Preparations